Clinical outcome in children with recurrent craniopharyngioma after primary surgery

被引:0
作者
Kalapurakal, JA
Goldman, S
Hsieh, YC
Tomita, T
Marymont, MH
机构
[1] NW Mem Hosp, Div Radiat Oncol, Childrens Mem Hosp, Chicago, IL 60611 USA
[2] NW Mem Hosp, Dept Prevent Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Childrens Mem Hosp, Div Hematol Oncol, Chicago, IL 60614 USA
[4] Northwestern Univ, Childrens Mem Hosp, Div Neurosurg, Chicago, IL 60614 USA
关键词
children; brain tumor; craniopharyngioma; local recurrence; radiotherapy; stereotactic radiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE The purpose of this article is to report the clinical outcome in children with recurrent craniopharyngioma after primary surgery. PATIENT AND MATERIALS Fourteen children with craniopharyngioma treated with primary surgery developed local recurrence. The median time to recurrence from primary surgery was 19 months (range, 2-156 months). At first recurrence (n = 14), seven children (50%) underwent reoperation. Five children (36%) received radiotherapy, and two children did not undergo any treatment. At second recurrence (n = 7), six children underwent radiotherapy (86%), and one had surgery. External-beam radiation was delivered with 6-MV or 10-MV x-rays by use of three-dimensional conformal technique (n = 4) or fractionated stereotactic radiotherapy (n = 7) using the Laitinen stereoadapter. Total dose ranged from 54 to 55.8 Gy at 1.8 Gy/fraction. RESULTS The median follow-up from primary surgery is 8.5 years (range, 3-15.8 years). The 5-, 10-, and 15-year overall survival was 100%, 86%, and 86%, respectively, and the disease-free survival was 92%, 60%, and 60%, respectively. The median follow-up from date of first relapse was 6 years (range, 2.5-10 years). After treatment far first recurrence, the 2- and 5-year second-recurrence-free survival was 71% and 29%, respectively. After radiotherapy, the 2- and 5-year second-recurrence-free survival was 100% and 100%, respectively, compared with 43% and 0%, respectively, for surgery alone. Univariate analysis revealed significantly superior local control with radiotherapy compared with surgery. The local control rate at last follow-up, after stratifying for treatment at first and second recurrence, were analyzed at first and second relapse was 90% and 0% after radiotherapy and surgery, respectively. If radiotherapy was used for first or second recurrence, the 5-, 10-, and 15-year relapse-free survival was 100%, 83%, and 83%, respectively, compared with 67%, 0%, and 0%, respectively, for surgery alone. The median time to second relapse after surgery for first relapse was 52 months (range, 2-36 months). After primary surgery, all 14 children developed panhypopituitarism, requiring lifelong hormone supplementation. After surgery at recurrence, three children (3/7, 43%) experienced intraoperative bleeding. resulting in permanent neurologic deficits in two. No child has shown any signs of radiation-induced optic neuropathy. DISCUSSION In children with recurrent craniopharyngioma after primary radical resection, the use of three-dimensional conformal radiotherapy or fractionated stereotactic radiotherapy results in very good local control with a low incidence of complications. In young children with stable tiny recurrences, a policy of close surveillance could be adopted for the brain to mature before beginning radiotherapy. The use of secondary surgery for recurrent tumors is associated with a low cure rate and a high risk of complications.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 23 条
[1]   Surgical treatment of craniopharyngiomas: experience with 168 patients [J].
Fahlbusch, R ;
Honegger, J ;
Paulus, W ;
Huk, W ;
Buchfelder, M .
JOURNAL OF NEUROSURGERY, 1999, 90 (02) :237-250
[2]   The role of radiation therapy in the management of craniopharyngioma: A 25-year experience and review of the literature [J].
Habrand, JL ;
Ganry, O ;
Couanet, D ;
Rouxel, V ;
Levy-Piedbois, C ;
Pierre-Kahn, A ;
Kalifa, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (02) :255-263
[3]   20-YEAR EXPERIENCE IN CHILDHOOD CRANIOPHARYNGIOMA [J].
HETELEKIDIS, S ;
BARNES, PD ;
TAO, ML ;
FISCHER, EG ;
SCHNEIDER, L ;
SCOTT, RM ;
TARBELL, NJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (02) :189-195
[4]   AGGRESSIVE SURGICAL-MANAGEMENT OF CRANIOPHARYNGIOMAS IN CHILDREN [J].
HOFFMAN, HJ ;
DESILVA, M ;
HUMPHREYS, RP ;
DRAKE, JM ;
SMITH, ML ;
BLASER, SI .
JOURNAL OF NEUROSURGERY, 1992, 76 (01) :47-52
[5]  
Jose C C, 1992, Clin Oncol (R Coll Radiol), V4, P287, DOI 10.1016/S0936-6555(05)81101-X
[6]  
Kalapurakal JA, 1999, RADIOLOGY, V213P, P237
[7]   Fractionated stereotactic radiotherapy for pediatric brain tumors: the Chicago children's experience [J].
Kalapurakal, JA ;
Kepka, A ;
Bista, T ;
Goldman, S ;
Tomita, T ;
Marymont, MH .
CHILDS NERVOUS SYSTEM, 2000, 16 (05) :296-302
[8]   Postoperative ectopic seeding of craniopharyngioma [J].
Lee, JH ;
Kim, CY ;
Kim, DG ;
Jung, HW .
JOURNAL OF NEUROSURGERY, 1999, 90 (04) :796-796
[9]   ENDOCRINE FUNCTION, MORBIDITY, AND MORTALITY AFTER SURGERY FOR CRANIOPHARYNGIOMA [J].
LYEN, KR ;
GRANT, DB .
ARCHIVES OF DISEASE IN CHILDHOOD, 1982, 57 (11) :837-841
[10]   CRANIOPHARYNGIOMA - LONG-TERM RESULTS FOLLOWING LIMITED SURGERY AND RADIOTHERAPY [J].
RAJAN, B ;
ASHLEY, S ;
GORMAN, C ;
JOSE, CC ;
HORWICH, A ;
BLOOM, HJG ;
MARSH, H ;
BRADA, M .
RADIOTHERAPY AND ONCOLOGY, 1993, 26 (01) :1-10